Stage IV Melanoma: Strategies to Support Shared Decision Making
| Overview / Abstract: |
Target Audience This activity is intended for oncology care providers (including physicians, advanced practice providers, nurses, and other HCPs) who care for patients with melanoma. Program Overview The explosion of therapeutic options for Stage IV disease has heralded improved outcomes for patients with Stage IV melanoma. However, this expanded array of available options brings increased complexity for decision making. This activity, Stage IV Melanoma: Strategies to Support Shared Decision Making, uses cases to illustrate state-of-the art management of Stage IV melanoma, with a particular emphasis on how to use the AIM at Melanoma Stage IV melanoma decision-making support tool and Patient Action Plans to support shared decision making. The faculty will also illustrate effective communication strategies in these case simulations. Multidisciplinary approaches will be encouraged, addressing strategies to provide consistent education and engagement across the oncology care team. Learning Objectives Upon completion of this activity, participants should be better able to: Describe the factors to consider in promoting shared decision making for stage IV melanoma |
|
Expiration |
Jun 01, 2023 |
|
Discipline(s) |
Nursing CNE, Physician CME |
|
Format |
Online |
|
Credits / Hours |
1.5 AMA PRA Category 1 Credit(s)™ |
|
Accreditation |
ACCME |
|
Presenters / Authors / Faculty |
Faculty FACULTY_NAME Anna Pavlick, BSN, MSc, DO, MBA, is a medical oncologist with more than 20 years of experience treating patients with skin cancer, including basal cell and squamous cell carcinoma, melanoma, and Merkel cell carcinoma. She is also an expert in treating ocular melanoma, eyelid tumors, and other rare solid tumor malignancies. Dr Pavlick earned her medical degree from the University of Medicine and Dentistry of New Jersey (UMDNJ)–Robert Wood Johnson Medical School; her Master of Science in human anatomy from Fairleigh Dickinson University; and her Bachelor of Science in biology and nursing from Fairfield University. She completed an internal medicine residency at UMDNJ and hematology and oncology fellowship training at Memorial Sloan Kettering Cancer Center, after which she joined the faculty of Weill Cornell Medicine, New York, NY, as Professor of Medicine in the Division of Hematology & Medical Oncology. She is the founding Director of the Cutaneous Oncology Program there and at New York-Presbyterian Hospital. Dr Pavlick’s major research interests include investigating targeted therapies, combination therapies, and immunotherapies. FACULTY_NAME Dr. Sunandana Chandra is an Associate Professor in Medicine in the Division of Hematology Oncology at Northwestern University. She focuses on advanced cutaneous malignancies and is the Co-Lead of the Northwestern Medicine Skin Disease Team and is a member of their early phase Developmental Therapeutics Program. She recently spearheaded the implementation of an Inpatient Immunotoxicity Consult Service at Northwestern and is a Co-Investigator in the Northwestern Immunotoxicity Biospecimen Registry. |
|
Sponsors / Supporters / Grant Providers |
Novartis Pharmaceuticals and Merck & Co, Inc. |
|
Keywords / Search Terms |
Relias LLC Relias LLC., FreeCME., Melanoma Free CE CME |
|